These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8837390)

  • 1. In-vitro activity of penicillin G plus sulbactam in comparison with other beta-lactamase inhibitor combinations and oxacillin against staphylococci.
    Jansen B; Perdreau-Remington F; Pulverer G
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):297-301. PubMed ID: 8837390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
    Hirano L; Bayer AS
    Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of beta-lactamase inhibitors on the activity of oxacillin against methicillin-resistant Staphylococcus aureus.
    Chang SC; Hsieh WC; Luh KT
    Diagn Microbiol Infect Dis; 1995 Feb; 21(2):81-4. PubMed ID: 7628197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureus.
    Kobayashi S; Arai S; Hayashi S; Sakaguchi T
    Antimicrob Agents Chemother; 1989 Mar; 33(3):331-5. PubMed ID: 2786369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.
    McDougal LK; Thornsberry C
    J Clin Microbiol; 1986 May; 23(5):832-9. PubMed ID: 3011847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ampicillin/sulbactam and amoxicillin/clavulanic acid for detection of borderline oxacillin-resistant Staphylococcus aureus.
    Liu H; Lewis N
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):47-51. PubMed ID: 1563385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.
    Jones RN
    Drugs; 1988; 35 Suppl 7():17-26. PubMed ID: 3265377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of selected antimicrobial agents against strains of Staphylococcus aureus isolated from bovine intramammary infections that produce beta-lactamase.
    Watts JL; Salmon SA
    J Dairy Sci; 1997 Apr; 80(4):788-91. PubMed ID: 9149974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of clinical isolates of Staphylococcus aureus for borderline susceptibility to antistaphylococcal penicillins.
    Varaldo PE; Montanari MP; Biavasco F; Manso E; Ripa S; Santacroce F
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):677-82. PubMed ID: 8243483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL; Monroy E; García O; Vaca S
    Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of sulbactam/ampicillin and ampicillin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Fabbri A; Tacchella A; Belli ML; Losurdo G
    Chemioterapia; 1988 Oct; 7(5):306-8. PubMed ID: 3224398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro activity and resistance behavior of the penicillins against Staph. aureus].
    Gussmann S
    Fortschr Med; 1982 Sep; 100(34):1577-8. PubMed ID: 6813210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci.
    Sierra-Madero JG; Knapp C; Karaffa C; Washington JA
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1754-7. PubMed ID: 3266728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S; Marre R
    Infection; 1991; 19(2):106-9. PubMed ID: 1646771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of penicillins alone and in combination with different agents against Staphylococcus aureus.
    Nosheen S; Ejaz H; Zafar A; Ikram H
    Pak J Pharm Sci; 2017 Mar; 30(2):393-397. PubMed ID: 28649062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
    Barry AL
    Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.